• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调强放疗同步整合加量与三维适形放疗序贯加量治疗局部晚期宫颈癌的剂量学比较研究

A Comparison of Intensity-Modulated Radiotherapy With Simultaneous Integrated Boost With Three-Dimensional Conformal Radiotherapy With Sequential Boost for Locally Advanced Cervical Cancer: A Dosimetric Study.

作者信息

Figueredo Negron Carlos Ivan, Gamboa Garay Oscar, Pabón Girón Alexandra, Esguerra Cantillo Jose Alejandro, Guerrero Lizcano Eduardo

机构信息

Radiation Oncology, Universidad Militar Nueva Granada, Instituto Nacional de Cancerología, Bogotá, D.C., COL.

Medical Physics, Instituto Nacional de Cancerología, Bogotá, D.C., COL.

出版信息

Cureus. 2022 Dec 25;14(12):e32940. doi: 10.7759/cureus.32940. eCollection 2022 Dec.

DOI:10.7759/cureus.32940
PMID:36712757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9879589/
Abstract

Objective The aim of this study was to compare the dosimetric criteria between the intensity-modulated radiation therapy (IMRT) technique with a simultaneous integrated boost (SIB) and the three-dimensional conformal radiation therapy (3DCRT) technique with a sequential boost (SB) plans for patients with locally advanced cervical cancer (LACC). Materials and methods A retrospective dosimetric comparison was performed in 15 patients with locally advanced cervical cancer who had previously been treated with fractions of 1.8 Gy up to doses of 45, 54-55.8, and 59.4 Gy in 28-33 sessions using the three-dimensional conformal radiation therapy (3DCRT) technique with a sequential boost (SB) and who had a new planning that was made using the intensity-modulated radiation therapy (IMRT) technique with a simultaneous integrated boost (SIB) in 25 sessions. The conformity index, quality of coverage, homogeneity index, mean doses, maximum doses, and different organ at risk (OAR) dose constraints were calculated for the dosimetric comparison of treatment plans. Descriptive analysis was performed using measures of central tendency and dispersion for the quantitative variables and absolute and relative frequencies for the qualitative variables. The comparison was made using the Wilcoxon signed rank sum test for a type I error level of 0.05. The statistical software Stata 11 (StataCorp LLC, College Station, Texas, USA) was used in the analysis. Results The mean age of the patients was 52 years, 33% were stage IIIB, and 67% had squamous cell carcinomas. The conformity index was 0.74 and 0.46 (difference: 0.28; p<0.01), the quality of coverage was 0.84 and 0.94 (difference: -0.10; p<0.01), and the homogeneity index was 0.12 and 0.070 (difference: 0.052; p<0.01) for IMRT-SIB and 3DCRT-SB, respectively. When the mean doses of the OARs were compared, all were lower with the IMRT-SIB technique, with statistically significant differences in the rectum and bladder. Conclusions The IMRT-SIB technique achieves a greater conformation of the doses on the treatment volumes with a significant reduction of the doses on the bladder and rectum.

摘要

目的 本研究旨在比较局部晚期宫颈癌(LACC)患者采用同步整合加量(SIB)的调强放射治疗(IMRT)技术与采用序贯加量(SB)的三维适形放射治疗(3DCRT)技术的剂量学标准。材料与方法 对15例局部晚期宫颈癌患者进行回顾性剂量学比较,这些患者此前采用三维适形放射治疗(3DCRT)技术及序贯加量(SB),以1.8 Gy的分次剂量进行28 - 33次治疗,剂量达45、54 - 55.8及59.4 Gy,现重新采用同步整合加量(SIB)的调强放射治疗(IMRT)技术进行25次治疗计划制定。计算适形指数、靶区覆盖质量、均匀性指数、平均剂量、最大剂量以及不同危及器官(OAR)的剂量约束,用于治疗计划的剂量学比较。对定量变量采用集中趋势和离散度测量进行描述性分析,对定性变量采用绝对和相对频率进行描述性分析。采用Wilcoxon符号秩和检验进行比较,I型错误水平设定为0.05。分析使用统计软件Stata 11(美国德克萨斯州大学城StataCorp有限责任公司)。结果 患者的平均年龄为52岁,33%为IIIB期,67%为鳞状细胞癌。IMRT - SIB和3DCRT - SB的适形指数分别为0.74和0.46(差值:0.28;p < 0.01),靶区覆盖质量分别为0.84和0.94(差值: - 0.10;p < 0.01),均匀性指数分别为0.12和0.070(差值:0.052;p < 0.01)。比较OAR的平均剂量时,IMRT - SIB技术的所有剂量均较低,直肠和膀胱的剂量差异具有统计学意义。结论 IMRT - SIB技术在治疗靶区实现了更好的剂量适形,同时显著降低了膀胱和直肠的剂量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3861/9879589/b1b8671a6f13/cureus-0014-00000032940-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3861/9879589/b1b8671a6f13/cureus-0014-00000032940-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3861/9879589/b1b8671a6f13/cureus-0014-00000032940-i01.jpg

相似文献

1
A Comparison of Intensity-Modulated Radiotherapy With Simultaneous Integrated Boost With Three-Dimensional Conformal Radiotherapy With Sequential Boost for Locally Advanced Cervical Cancer: A Dosimetric Study.调强放疗同步整合加量与三维适形放疗序贯加量治疗局部晚期宫颈癌的剂量学比较研究
Cureus. 2022 Dec 25;14(12):e32940. doi: 10.7759/cureus.32940. eCollection 2022 Dec.
2
Dosimetric comparison of standard three-dimensional conformal radiotherapy followed by intensity-modulated radiotherapy boost schedule (sequential IMRT plan) with simultaneous integrated boost-IMRT (SIB IMRT) treatment plan in patients with localized carcinoma prostate.局限性前列腺癌患者中标准三维适形放疗后序贯调强放疗推量方案(序贯调强放疗计划)与同步整合推量调强放疗(SIB IMRT)治疗计划的剂量学比较
Indian J Urol. 2012 Jul;28(3):300-6. doi: 10.4103/0970-1591.102707.
3
Breast-conserving radiotherapy with simultaneous integrated boost; field-in-field three-dimensional conformal radiotherapy versus inverse intensity-modulated radiotherapy - A dosimetric comparison: Do we need intensity-modulated radiotherapy?保乳放疗同步整合加量;野中野三维适形放疗与逆向调强放疗的剂量学比较:我们是否需要调强放疗?
South Asian J Cancer. 2018 Jul-Sep;7(3):163-166. doi: 10.4103/sajc.sajc_82_18.
4
Simultaneously integrated boost (SIB) spares OAR and reduces treatment time in locally advanced cervical cancer.同时整合增敏(SIB)可保护危及器官并缩短局部晚期宫颈癌的治疗时间。
J Appl Clin Med Phys. 2016 Sep 8;17(5):76-89. doi: 10.1120/jacmp.v17i5.6123.
5
A dosimetric comparison between three-dimensional conformal radiation therapy and intensity-modulated radiation therapy in the treatment of posterior fossa boost in medulloblastoma.三维适形放射治疗与调强放射治疗在髓母细胞瘤后颅窝追加剂量治疗中的剂量学比较
J Cancer Res Ther. 2017 Oct-Dec;13(6):1027-1031. doi: 10.4103/0973-1482.220416.
6
Intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) in a patient with left breast cancer and pectus excavatum.左侧乳腺癌伴漏斗胸患者的调强放疗(IMRT)同步整合增敏(SIB)。
Clin Transl Oncol. 2012 Oct;14(10):747-54. doi: 10.1007/s12094-012-0862-7. Epub 2012 Jul 19.
7
Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing.不同调强放疗增敏递送方法对靶区覆盖和正常组织保护的评估。
Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1480-91. doi: 10.1016/s0360-3016(03)01569-4.
8
Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.同步整合调强放疗加量治疗局部晚期妇科癌症:放射生物学和剂量学考量
Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):933-9. doi: 10.1016/j.ijrobp.2004.11.040.
9
Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer.调强适形放疗同步整合加量治疗高危前列腺癌的剂量学优势
Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1251-7. doi: 10.1016/j.ijrobp.2004.11.034.
10
Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach.子宫颈癌放射治疗中子宫旁组织和子宫颈同步整合加量(SIB):一种使用新替代方法的剂量学研究
Br J Radiol. 2016 Dec;89(1068):20160526. doi: 10.1259/bjr.20160526. Epub 2016 Oct 6.

引用本文的文献

1
The impact of bladder volume on dosimetric outcomes in VMAT for cervical cancer patients after surgery.膀胱容积对宫颈癌术后患者容积调强放疗剂量学结果的影响。
J Gynecol Oncol. 2025 Jul;36(4):e65. doi: 10.3802/jgo.2025.36.e65. Epub 2025 Apr 8.
2
Intensity-Modulated Radiation Therapy for Uterine Cervical Cancer to Reduce Toxicity and Enhance Efficacy - an Option or a Must?: A Narrative Review.调强放疗治疗宫颈癌以降低毒性并提高疗效——是一种选择还是必须?:一篇叙述性综述。
Cancer Res Treat. 2024 Jan;56(1):1-17. doi: 10.4143/crt.2023.562. Epub 2023 Aug 30.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline.宫颈癌放射治疗:ASTRO 临床实践指南摘要。
Pract Radiat Oncol. 2020 Jul-Aug;10(4):220-234. doi: 10.1016/j.prro.2020.04.002. Epub 2020 May 18.
3
Dosimetric and radiobiological comparison of simultaneous integrated boost and sequential boost of locally advanced cervical cancer.
局部晚期宫颈癌同步整合推量与序贯推量的剂量学和放射生物学比较。
Phys Med. 2020 May;73:83-88. doi: 10.1016/j.ejmp.2020.04.012. Epub 2020 Apr 22.
4
Improvement in Patient-Reported Outcomes With Intensity-Modulated Radiotherapy (RT) Compared With Standard RT: A Report From the NRG Oncology RTOG 1203 Study.与标准放疗相比,调强放疗(IMRT)改善患者报告结局:NRG 肿瘤学 RTOG 1203 研究报告。
J Clin Oncol. 2020 May 20;38(15):1685-1692. doi: 10.1200/JCO.19.02381. Epub 2020 Feb 19.
5
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer.欧洲妇科肿瘤学会/欧洲放射肿瘤学会/欧洲病理学会关于宫颈癌管理患者的指南。
Virchows Arch. 2018 Jun;472(6):919-936. doi: 10.1007/s00428-018-2362-9. Epub 2018 May 4.
6
The prognostic impact of overall treatment time on disease outcome in uterine cervical cancer patients treated primarily with concomitant chemoradiotherapy: a nationwide Taiwanese cohort study.总体治疗时间对主要接受同步放化疗的子宫颈癌患者疾病预后的影响:一项台湾全国性队列研究。
Oncotarget. 2017 Jul 27;8(49):85203-85213. doi: 10.18632/oncotarget.19617. eCollection 2017 Oct 17.
7
Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.宫颈癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2017 Jul 1;28(suppl_4):iv72-iv83. doi: 10.1093/annonc/mdx220.
8
Simultaneous integrated boost (SIB) for treatment of gynecologic carcinoma: Intensity-modulated radiation therapy (IMRT) vs volumetric-modulated arc therapy (VMAT) radiotherapy.同步整合加量(SIB)治疗妇科恶性肿瘤:调强放射治疗(IMRT)与容积调强弧形放疗(VMAT)的比较
Med Dosim. 2017;42(3):230-237. doi: 10.1016/j.meddos.2017.05.002. Epub 2017 Jul 12.
9
Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).保骨髓强度调制放疗同步顺铂治疗 IB-IVA 期宫颈癌的国际多中心 II 期临床试验(INTERTECC-2)。
Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):536-545. doi: 10.1016/j.ijrobp.2016.11.027. Epub 2016 Nov 23.
10
Simultaneous integrated boost (SIB) of the parametrium and cervix in radiotherapy for uterine cervical carcinoma: a dosimetric study using a new alternative approach.子宫颈癌放射治疗中子宫旁组织和子宫颈同步整合加量(SIB):一种使用新替代方法的剂量学研究
Br J Radiol. 2016 Dec;89(1068):20160526. doi: 10.1259/bjr.20160526. Epub 2016 Oct 6.